BACE1 and Alzheimer disease: In conclusion, PPARδ activation with 5a leads to favorable effects on amyloid burden via multiple mechanisms that inhibit excessive inflammation, oxidative stress, and increased levels of BACE1, which are all risk factors for Aβ deposition, thereby restoring cognitive impairment in the mouse models of AD.